Treating Insomnia in Family Practice
All adult patients with chronic insomnia should receive cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, and pharmacologic therapy should only be added short-term through shared decision-making if CBT-I fails. 1
Initial Treatment Approach
Start with CBT-I as the mandatory first-line intervention for all adults with chronic insomnia disorder 1. This is a strong recommendation based on moderate-quality evidence showing improved sleep outcomes (reduced sleep onset latency, wake after sleep onset, improved sleep efficiency) and global outcomes (remission rates, treatment response) with minimal harms 1.
What CBT-I Actually Includes:
- Cognitive therapy addressing dysfunctional beliefs about sleep
- Behavioral interventions: sleep restriction and stimulus control
- Sleep hygiene education (though insufficient alone) 2
Delivery Methods (All Effective):
- In-person individual or group therapy
- Telephone-based modules
- Web-based/digital programs 3, 4
- Self-help books 1
Critical point: CBT-I can be performed in primary care settings 1. Digital CBT-I is increasingly accessible and addresses the availability barrier 3, 4.
When to Add Pharmacotherapy
Only consider medications if CBT-I alone fails 1. Use shared decision-making discussing benefits, harms, and costs of short-term use only 1.
Evidence-Based Medication Options:
For sleep initiation and maintenance:
- Low-dose doxepin (evidence-based option) 5
- Dual orexin receptor antagonists (suvorexant, lemborexant, daridorexant) - effective for both sleep onset and maintenance, safe up to 3 months 6, 7
- Melatonin receptor agonists (ramelteon) - safer but limited effectiveness 6
For short-term use (≤4 weeks):
- Z-drugs (zolpidem, eszopiclone) - improved sleep outcomes in general population 1, safe in depression/anxiety but avoid in older adults due to cognitive impairment, falls, and fractures 1
- Benzodiazepines - short-term only (up to 4 weeks), triazolam for sleep-onset/middle-of-night insomnia 7
Off-label but commonly used:
- Trazodone - most prescribed off-label treatment, effective for sleep initiation and maintenance, lacks abuse potential 3
Critical Warnings:
The FDA specifically warns about serious adverse effects with hypnotics including:
- Dementia and fractures (observational data) 1
- Cognitive and behavioral changes
- Driving impairment and motor vehicle accidents 1
- Lower doses required for women, older adults, and debilitated patients 1
What NOT to Use:
- Antihistamines (diphenhydramine) - lacking evidence except doxylamine effective up to 4 weeks only 6
- Antipsychotics - not recommended 7
- Commonly prescribed older medications (diphenhydramine, trazodone) - inadequately studied in trials despite widespread use 1
Dosing Strategy
Use the lowest effective dose for the shortest duration 3. Consider:
- As-needed basis rather than nightly 3
- Non-nightly use for patients not requiring daily treatment 7
- Maximum 6 weeks for nightly use 3
- Up to 3 months for orexin receptor antagonists 7
Special Populations
Older adults:
- More likely to have sleep maintenance problems than sleep onset issues 1
- Avoid benzodiazepines and Z-drugs due to falls, fractures, cognitive impairment 1
- Consider orexin receptor antagonists (safe with mild cognitive impairment) 3
Patients with psychiatric comorbidities:
- Z-drugs are safe and effective in depression/anxiety 3
- Orexin receptor antagonists require further study in psychiatric populations 3
Common Pitfalls to Avoid
- Skipping CBT-I and going straight to medications - violates evidence-based guidelines 1
- Long-term hypnotic use - FDA recommends short-term only, but many patients continue extended periods 1
- Using benzodiazepines/Z-drugs in older adults - high risk of serious adverse events 1
- Relying on sleep hygiene alone - necessary but insufficient as monotherapy 2
- Not screening for contributing factors: sleep apnea, restless legs syndrome, narcolepsy, medications, medical/psychiatric diagnoses, substance use 3
Documentation Requirements
Document the specific insomnia type:
- Difficulty falling asleep (sleep onset latency)
- Difficulty maintaining sleep (wake after sleep onset)
- Early morning awakening
- Resulting functional impairment
- Duration (short-term vs. persistent ≥3 months) 3